Characteristics

CML Patients

p value

IM Responders (n = 22)

IM non-responders (n = 26)

Sex

Males/females

9/13

13/13

0.76

Age at diagnosis (y)

mean (range)

49.0 (23 - 80)

44.1 (24 - 62)

0.22

Transcript type

b2a2, N

5

11

0.18

b3a2, N

17

14

0.60

b2a2 + b3a3, N

0

1

0.45

Sokal score

Low, N

7

11

0.32

Intermediate, N

8

10

0.83

High, N

7

5

0.79

Achievement of CCyR within 6 months, N

22

10

0.36

Treated with dasatinib, N

-

10

-

Treated with nilotinib, N

-

16

-

Primary failure of IM, N

-

20

-

Secondary failure of IM, N

-

6

-